Skip to main content

Table 2 Follow-up outcomes by presence of DM with corresponding HR

From: Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Outcome

DM

Non-DM

Adjusted HR* (95% CI)

All-cause death

171/373 (45.8%)

243/736 (33%)

1.40 (1.11–1.75)

CV-death

130/373 (34.9%)

173/736 (23.5%)

1.39 (1.07–1.81)

Sudden cardiac death

72/373 (19.3%)

80/736 (10.9%)

1.73 (1.19–2.52)

HF-realetd death

50/373 (13.4%)

71/736 (9.6%)

1.28 (0.86–1.91)

Major bleeding**

18/340 (5.3%)

29/644 (4.5%)

1.50 (0.78–2.87)

Stroke**

24/340 (7.1%)

28/645 (4.3%)

1.87(1.01–3.45)

AF-related hospitalization**

59/340 (17.4%)

115/645 (17.8%)

1.17 (0.82–1.66)

HF-related hospitalization**

35/333 (10.5%)

46/640 (7.2%)

1.40 (0.89–2.21)

Hospitalization or CV-death

243/373 (65.1%)

399/736 (54.2%)

1.27 (1.06–1.53)

  1. Significant adjusted hazard ratios are marked in italics
  2. *Adjusted for: age, BMI, history of prior stroke, coronary artery disease or prior revascularization procedure, AF subtype, eGFR (CKD-EPI) and use of ACEI-ARB, OAC and rate control medication after discharge
  3. **Competing-risks regression analysis (Fine and Gray 1999) was performed with all-cause death addressed as a competing risk
  4. DM: diabetes mellitus; HR: hazard ratio; AF: atrial fibrillation; CV: cardiovascular; HF: heart failure